D.C. delays revoking Union Market cannabis license
District regulators have temporarily halted their attempt to revoke the medical cannabis license of Union Market retailer Mirage, Inc. —not because the business is off the hook, but because a faster legal path opened up. Mirage originally faced license cancellation and a denied safekeeping request in May after failing to open within the mandatory 120-day window following its licensing, but the dispute escalated on July 10 when the Alcoholic Beverage and Cannabis (ABC) Board hit the company with a Notice of Summary Revocation, initiating direct enforcement action. In a July 22 ruling, the Board officially stayed its initial failure-to-open revocation proceeding to prioritize the active summary enforcement case; once that hearing concludes, regulators will determine whether to lift the stay or finalize revoking the license.
- The next ABC Board meeting is Aug. 12: watch, agenda (no cannabis items).
- Catch up on the Aug. 5th disposition or subscribe to a paying membership to receive exclusive summaries of Board meetings and see our map of pending cannabis businesses in D.C.
- The ABC Board will observe summer recess starting this week from August 13 – September 15.
At its July 22, 2026 meeting, the Virginia Cannabis Control Authority (CCA) Board of Directors officially set key milestones for the Commonwealth’s commercial adult-use marketplace—announcing that retail applications will open on February 1, 2027, followed by conditional license awards on May 1, 2027—while unanimously approving an expanded $26.2 million FY27 budget ($5.7M General Fund / $20.5M Non-General Fund) to scale up enforcement, build out a unified licensing system, and absorb hemp oversight from VDACS; however, the board faced heavy pushback during public comments regarding potential license lotteries, recent census tract redistricting that stripped several equity applicants of Historically Economically Disadvantaged Community (HEDC) status, and widespread public confusion caused by social media misinformation.
ICYMI: Family Feud Derails ‘Blunt DC’ Sale After Unauthorized License Transfer
East Coast Roundup
As retail market maturing in New England leads to price compression, operators face tightening margins across state lines with wholesale and retail cannabis prices dropping in Vermont and Massachusetts.
Governor Kathy Hochul signed legislation formally extending and codifying legal cannabis “showcases,” giving New York microbusinesses and growers expanded, flexible retail opportunities to move inventory outside traditional brick-and-mortar stores.
Marking a successful inaugural year of adult-use sales, Delaware generated over $53 million in recreational cannabis revenue, driving market expansion while highlighting persistent federal banking barriers for new operators.
Culture & More
Navigating interstate air travel remains a compliance challenge for consumers and businesses alike, as TSA maintains its stance of deferring cannabis enforcement to local law enforcement while federally prohibiting cannabis across airport checkpoints.
Routine hospital drug screening policies that land new mothers on child abuse registries for trace THC levels pose growing legal, medical, and ethical risks for patient retention and brand reputation across the health and wellness sector.
Rising emergency room visits tied to Cannabis Hyperemesis Syndrome (CHS) emphasize the urgent need for brands and retailers to proactively educate consumers on high-potency product dosage and usage risks.
Around the Country
Texas hemp operators filed a federal lawsuit alleging that state health officials violated the U.S. Constitution’s commerce clause by reclassifying delta-8 and other hemp-derived THC variants as Schedule I felonies overnight.
Recent revenue figures show California’s legal market continuing its protracted fight against illicit competition, with operators managing shifting sales trends amid heavy state taxation and regulatory burdens.
Wisconsin consumable hemp manufacturers are lobbying for delayed state-level bans in hopes that federal regulators will establish clear, standardized rules for hemp-derived THC products in the next Farm Bill.
From the swamp
Federal lawmakers, led by Sen. Ted Budd and federal health officials like Dr. Mehmet Oz, are pushing spending bill amendments aimed at closing the 2018 Farm Bill loophole to strictly limit or ban intoxicating hemp–derived cannabinoids nationwide.
